Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
J-147
Cat. No.:
OB0225LY-0092
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
J-147 is a novel compound that exhibits neuroprotective effects.
Synonym:
J147; 1146963-51-0; N-(2,4-Dimethylphenyl)-2,2,2-trifluoro-N-[(E)-(3-methoxyphenyl)methylideneamino]acetamide; Acetic acid, 2,2,2-trifluoro-, 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide; N-(2,4-Dimethylphenyl)-2,2,2-trifluoro-N'-(3-methoxybenzylidene)acetohydrazide; Acetic acid, 2,2,2-trifluoro-, 1-(2,4-dimethylphenyl)-2-((3-methoxyphenyl)methylene)hydrazide; N-(2,4-Dimethylphenyl)-2,2,2-trifluoro-N-((E)-(3-methoxyphenyl)methylideneamino)acetamide
CAS No.:
1146963-51-0
Compound CID:
25229652
Formula:
C18H17F3N2O2
Formula Weight:
350.33
Specification
Relative Density:
1.131 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
J-147 is primarily used in the study of neurodegenerative diseases, especially in improving cognitive function and slowing disease progression.
Library Information
Targets:
Epigenetic reader domain; Dopamine receptor; Monoamine Oxidase
Receptors:
Monoamine oxidase B
Pathways:
Neuronal signaling; GPCR/G protein; Chromatin/Epigenetic
Plate Number:
AOCL-2
Plate Location:
b5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 128.45 mM
